![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Cancer Management & Treatment | Cancer Research & Drug Trials
Cancer Therapy Advisor offers the latest cancer management and treatment info, cancer research news, and more for oncologists and medical professionals.
Side Effects of Radiation for Prostate Cancer - Cancer Therapy …
Sep 6, 2024 · Prostate cancer remains the most common cancer in men, affecting approximately 1 of every 8 individuals. 1 The standard treatments for prostate cancer include active surveillance, prostatectomy ...
Hypercalcemia in Cancer: Causes, Symptoms, and Management
Nov 17, 2023 · Hypercalcemia affects up to 30% of patients with cancer. 1 It has been seen in most cancers but is most common in patients with non-small cell lung cancer, breast cancer, multiple myeloma, head ...
Anastrozole vs Tamoxifen: Similar Outcomes, Different Toxicities
Dec 9, 2020 · Long-term data on ductal carcinoma in situ (DCIS) from the IBIS-II DCIS trial showed that anastrozole and tamoxifen have comparable efficacy, but different safety profiles in postmenopausal women ...
Breast Cancer Awareness Month: Its History, Impact, and the Pink …
Sep 18, 2023 · October is National Breast Cancer Awareness Month, a time to provide education on the condition and encourage awareness about screening and early detection.
SABCS 2024: Improving Treatment for Early Breast Cancer
Dec 20, 2024 · Research presented at the San Antonio Breast Cancer Symposium 2024 highlighted efforts to expand treatment options for early breast cancer but also de-escalate treatment, reducing toxicity without ...
Top Breast Cancer Research of 2024 - Cancer Therapy Advisor
Dec 30, 2024 · Scroll down for links to articles highlighting the top breast cancer research published on Cancer Therapy Advisor in 2024. HER2-Low Breast Cancer: Despite New Data, Questions Persist
Opdivo Qvantig Approved to Treat Solid Tumor Malignancies
The US Food and Drug Administration has approved subcutaneous nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) for some of the same indications as intravenous nivolumab (Opdivo).
ASH 2024: Multiple Myeloma Studies May Change Practice
Dec 18, 2024 · Source: Science Source Images The IFM2017-03 trial, which showed positive results with a dexamethasone-sparing regimen, is “one of the most practice-changing” studies presented at ASH 2024 ...
Malignant Ascites: Diagnosis and Management - Cancer Therapy …
Apr 27, 2015 · Ascites refers to fluid that accumulates within the peritoneal cavity. Although ascites is most commonly observed in patients with cirrhosis and resulting portal hypertension (approximately 85% of ...